![Frank W. Marcoux](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frank W. Marcoux
Algemeen Directeur bij Portage Glasgow Ltd.
Actieve functies van Frank W. Marcoux
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Portage Pharma Ltd.
![]() Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Hoofd Techniek/Wetenschap/O&O | 04-06-2013 | - |
Opsidio LLC
![]() Opsidio LLC Pharmaceuticals: MajorHealth Technology Opsidio LLC engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company is headquartered in Bryn Mawr, PA. | Directeur/Bestuurslid | - | - |
Portage Glasgow Ltd.
![]() Portage Glasgow Ltd. Pharmaceuticals: MajorHealth Technology Portage Glasgow Ltd. develops drugs to treat chronic conditions. The private company is based in Glasgow. The CEO of the American company is Frank W. Marcoux. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | - | - | |
Portage Pharmaceutical Ltd.
![]() Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Algemeen Directeur | - | - |
Loopbaan van Frank W. Marcoux
Eerdere bekende functies van Frank W. Marcoux
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PORTAGE BIOTECH INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
Statistieken
Internationaal
Verenigde Staten | 3 |
Canada | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sectoraal
Health Technology | 5 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PORTAGE BIOTECH INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Portage Pharma Ltd.
![]() Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Health Technology |
Portage Pharmaceutical Ltd.
![]() Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Commercial Services |
Opsidio LLC
![]() Opsidio LLC Pharmaceuticals: MajorHealth Technology Opsidio LLC engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company is headquartered in Bryn Mawr, PA. | Health Technology |
Portage Glasgow Ltd.
![]() Portage Glasgow Ltd. Pharmaceuticals: MajorHealth Technology Portage Glasgow Ltd. develops drugs to treat chronic conditions. The private company is based in Glasgow. The CEO of the American company is Frank W. Marcoux. | Health Technology |
- Beurs
- Insiders
- Frank W. Marcoux
- Ervaring